Sixteen patients (11 men, mean age 61.7 years) with histopathologically proven NSCLC were selected, and the PD-L1 expression (0–85%) in primary tumors was determined beforehand by immunohistochemistry. This evidence concerns the gene CD274 and non-small cell lung carcinoma.